A cautionary tale: dosing chemotherapy in infants with retinoblastoma.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

13 citing papers in PubMed, 4 syntheses or guidelines pooled it.

1. Clinical pharmacology of cytotoxic drugs in neonates and infants: Providing evidence-based dosing guidance.European journal of cancer (Oxford, England : 1990) · 2022
   Pooled it
2. Different infusion durations for preventing platinum-induced hearing loss in children with cancer.The Cochrane database of systematic reviews · 2020
   Pooled it
3. Different infusion durations for preventing platinum-induced hearing loss in children with cancer.The Cochrane database of systematic reviews · 2018
   Pooled it
4. Platinum-induced hearing loss after treatment for childhood cancer.The Cochrane database of systematic reviews · 2016
   Pooled it
5. Adjuvant Chemotherapy Improves Survival for Children With Massive Choroidal Invasion of Retinoblastoma.Investigative ophthalmology & visual science · 2023
   Article
6. Aurora Kinase B Expression, Its Regulation and Therapeutic Targeting in Human Retinoblastoma.Investigative ophthalmology & visual science · 2021
   Article
7. Endovascular approaches in pediatric interventional oncology.CVIR endovascular · 2021
   Review
8. Carboplatin therapeutic monitoring in preterm and full-term neonates.European journal of cancer (Oxford, England : 1990) · 2015
   Article
9. Risk definition and management strategies in retinoblastoma: current perspectives.Clinical ophthalmology (Auckland, N.Z.) · 2015
   Review
10. Tandem therapy for retinoblastoma: immunotherapy and chemotherapy enhance cytotoxicity on retinoblastoma by increasing apoptosis.Journal of cancer research and clinical oncology · 2013
    Article
11. Retinoblastoma frontiers with intravenous, intra-arterial, periocular, and intravitreal chemotherapy.Eye (London, England) · 2013
    Review
12. Long-term follow-up of retinoblastoma survivors: Experience from India.South Asian journal of cancer
    Article
13. Retinal Optical Coherence Tomography Angiography Findings following Retinoblastoma Treatment by Chemotherapy.Journal of current ophthalmology
    Article

Corrections and comments

• Commented on by
  Carboplatin dosing in infants with retinoblastoma: a case for therapeutic drug monitoring.2012
• Comment on
  Carboplatin-associated ototoxicity in children with retinoblastoma.2012

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as